Skip to main content
Clinical Trials/ISRCTN34571027
ISRCTN34571027
Completed
未知

Efficacy and safety of iontophoresis in patients with age-related cataract: a single-center, randomized, double-masked, controlled trial

Zhongshan Ophthalmic Center0 sites118 target enrollmentMarch 19, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Age-related cataract
Sponsor
Zhongshan Ophthalmic Center
Enrollment
118
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 19, 2015
End Date
June 1, 2015
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Zhongshan Ophthalmic Center

Eligibility Criteria

Inclusion Criteria

  • 1\. ?Adults between the ages of 65 and 80 years old
  • 2\.? LOCS III nuclear opalescence score \>\=3\.0 OR cortical cataract score \>\=3\.0 OR posterior subcapsular score \>\=1\.0 bilateral
  • 3\.? Able to commit to the 4\-week follow up
  • 4\. ?Able to understand and sign an informed consent

Exclusion Criteria

  • 1\.? Types of cataracts other than age\-related, including metabolic cataract, drugs and toxic cataract, congenital cataract, etc
  • 2\. ?Any other ocular pathology that may affect visual acuity, such as glaucoma, uveitis and retinopathy, etc
  • 3\.? Patients with inflammation of the ocular surface and the adjacent area
  • 4\.? History of ocular surgery or laser
  • 5\. ?Patients who are blind in one eye
  • 6\. ?Patients with uncontrolled systemic disease, i.e. high blood pressure (Bp \> 160/100 mmHg), diabetes mellitus (GLU\-AC \>8mg/dl), kidney disease, etc

Outcomes

Primary Outcomes

Not specified

Similar Trials